Baseline microperimetry and metabolic status predict functional outcomes in diabetic macular oedema: a prospective cohort study of anti-VEGF therapy
{{output}}
Aims: Diabetic macular oedema (DME) is a leading cause of visual impairment with anti-vascular endothelial growth factor (anti-VEGF) therapy representing first-line treatment. However, best-corrected visual acuity (BCVA) cannot f... ...
